Skip to main content
Back to Investors

Earlybird Venture Capital Portfolio Companies

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

Last updated: July 2026

Earlybird Venture Capital Investment Overview

Portfolio Companies
136
Total Invested
$1.5B
Average Investment
$16.9M

Earlybird Venture Capital's Most Recent Investments (2020+)

Company NameFoundedFunding StageAmountCity
Nosh Biofoods2024SeedUndisclosedBerlin
ottonova2022Series FUndisclosedMunich
HAYA Therapeutics2025GrantUndisclosedLausanne
ImCheck Therapeutics2024GrantUndisclosedMarseille
CELUS2022Series AUndisclosedMunich
TopK2025SeedUndisclosedSan Francisco
Isar Aerospace2026Series DUndisclosedMunich
Portal Biotech2025Series AUndisclosedLondon
Priothera2025GrantUndisclosedDublin
TILT2026Series B$18.1MLondon

Complete List of Earlybird Venture Capital Portfolio Companies (136)

Export
#CompanyStageAmountLocation
1Nosh BiofoodsSeedUndisclosedBerlin, Germany
2ottonovaSeries FUndisclosedMunich, Germany
3HAYA TherapeuticsGrantUndisclosedLausanne, Switzerland
4ImCheck TherapeuticsGrantUndisclosedMarseille, France
5CELUSSeries AUndisclosedMunich, Germany
6TopKSeedUndisclosedSan Francisco, United States
7Isar AerospaceSeries DUndisclosedMunich, Germany
8Portal BiotechSeries AUndisclosedLondon, United Kingdom
9PriotheraGrantUndisclosedDublin, Ireland
10TILTSeries B$18.1MLondon, United Kingdom
Food and BeverageFood ProcessingNutrition

Nosh Biofoods is a meat producer that employs fermentation technology to provide nutritious and flavorful options for the food sector.

Berlin, Germany
September 2024
Seed

Founder Contacts

19,000+ verified contacts

Health CareHealth InsuranceInsuranceInsurTech

ottonova is Germany's newest and purely digital health insurance

Munich, Germany
September 2022
Series F

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.

Lausanne, Switzerland
September 2025
Grant

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics

ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.

Marseille, France
August 2024
Grant

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Software

Engineering platform to automate the development of electronics

Munich, Germany
July 2022
Series A

Founder Contacts

19,000+ verified contacts

Information TechnologySoftware

TopK is a serverless, cloud-native, document database built for powering search applications.

San Francisco, United States
July 2025
Seed

Founder Contacts

19,000+ verified contacts

AerospaceManufacturingSpace Travel

Isar Aerospace builds and operates launch vehicles for transporting small and medium-sized satellites into Earth’s orbit.

Munich, Germany
June 2026
Series D

Founder Contacts

19,000+ verified contacts

Biotechnology

Portal Biotech is a biotechnology company specializing in advanced proteomics and metabolomics through single-molecule detection.

London, United Kingdom
June 2025
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.

Dublin, Ireland
June 2025
Grant

Founder Contacts

19,000+ verified contacts

AppsE-CommerceShoppingVideo Streaming

TILT app is an online shopping platform that allows users to buy through videos, live streams, and earn rewards.

London, United Kingdom
June 2026
$18.1M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Human ResourcesRecruitingStaffing Agency

MONA AI is an AI-powered recruitment platform that automates candidate sourcing, screening, matching, and hiring workflows for businesses.

Saarbrücken, Germany
June 2026
$2.1M
Seed

Founder Contacts

19,000+ verified contacts

BlockchainFinTechGamingMobileVideo Games

Living Assets: NFT 2.0. Evolving - Scalable - Multicurrency - Sustainable - Certifiable.

Barcelona, Spain
May 2022
Series A

Founder Contacts

19,000+ verified contacts

ComputerHardwareInformation TechnologyQuantum ComputingSemiconductor

eleQtron develops and operates trapped-ion quantum computers built for industrial and scientific use.

Siegen, Germany
May 2026
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Industrial AutomationMachine LearningSoftware

EthonAI is an AI-powered platform that detects and prevents manufacturing defects.

Zürich, Switzerland
May 2024
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Consumer ElectronicsHealth CareHealth DiagnosticsMedical DeviceMobileMobile AppsPersonal HealthWearables

Hilo by Aktiia provides a wearable band, calibration cuff, and app for cuffless continuous blood pressure monitoring.

Neuchâtel, Switzerland
May 2025
Series B

Founder Contacts

19,000+ verified contacts

AppsAudioContentDigital MediaNewsPublishing

Curio is a platform that allows individuals to stay informed by listening to human-narrated news from reliable publications.

London, United Kingdom
May 2023
Undisclosed

Founder Contacts

19,000+ verified contacts

Health CareHealth DiagnosticsMedical DevicePersonal Health

Hilo is a healthcare company that provides blood pressure, digital therapeutics, and patient management services.

Neuchâtel, Switzerland
May 2025
$42.0M
Series B

Founder Contacts

19,000+ verified contacts

Pillar is shaping a world where every construction company is resilient and financially sound.

Milano, Italy
May 2026
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Cloud Data ServicesCloud InfrastructureDatabaseData ManagementOpen Source

Aiven is a technology-driven company that enables businesses to manage an open-source data infrastructure in the cloud.

Helsinki, Finland
May 2022
Series D

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Web Development

The Interaction Company's Poke is an AI assistant that lives fully inside iMessage and integrates seamlessly.

Palo Alto, United States
April 2026
$15.0M
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Computer VisionConstructionSoftware

CONXAI develops a no-code artificial intelligence platform to automate knowledge-intensive workflows in the construction industries.

Munich, Germany
April 2026
$2.1M
Series A

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical Device

Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.

Palo Alto, United States
March 2026
$50.0M
Series C

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Clinical TrialsSoftware

Rivia is a next-gen operating system for improved trial outcomes.

Zürich, Switzerland
March 2026
$15.0M
Series A

Founder Contacts

19,000+ verified contacts

Food and BeverageFood DeliveryFood Processing

TastyUrban is in the process of developing a new generation of restaurant usage and strategy.

Berlin, Germany
March 2025
Series A

Founder Contacts

19,000+ verified contacts

BlockchainFinanceFinTechInformation Technology

Obligate allows companies to issue on-chain bonds and commercial paper to receive funding from investors in a regulated DeFi environment.

Zürich, Switzerland
October 2025
$3.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Showing 1-25 of 136 portfolio companies

Frequently Asked Questions About Earlybird Venture Capital

How many companies has Earlybird Venture Capital invested in?

Earlybird Venture Capital has invested in 136 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Earlybird Venture Capital invest in?

Earlybird Venture Capital's top investment sectors include Artificial Intelligence (AI), Health Care, Software, Biotechnology, Medical. The firm invests across 60 different industry categories.

What is Earlybird Venture Capital's largest investment?

Among tracked funding rounds, Polares Medical received $50.0M in a Series C round. Earlybird Venture Capital's total known invested capital is $1.5B.

What is the average investment size for Earlybird Venture Capital?

Earlybird Venture Capital's average investment size is $16.9M across its portfolio of 136 companies.

What are Earlybird Venture Capital's most recent investments?

Recent Earlybird Venture Capital portfolio additions include Nosh Biofoods, ottonova, HAYA Therapeutics, ImCheck Therapeutics, CELUS. These companies were founded in 2020 or later.

Explore Other Top Investors

Discover portfolio companies of other leading venture capital firms and investors.

View All Investors